Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer. Issue 10 (October 2017) - Patrikidou, A.; Uccello, M.; Tree, A.; Parker, C.; Attard, G.; Eeles, R.; Khoo, V.; van As, N.; Huddart, R.; Dearnaley, D.; Reid, A.